Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury-Reference-Cited by-同舟云学术

Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury

Published:2012-04-15 Issue:5 Volume:18 Page:759-765
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Islam Mohammad Naimul,Das Shonit R,Emin Memet T,Wei Michelle,Sun Li,Westphalen Kristin,Rowlands David J,Quadri Sadiqa K,Bhattacharya Sunita,Bhattacharya Jahar

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2736.pdf

Reference40 articles.

1. Prockop, D.J., Kota, D.J., Bazhanov, N. & Reger, R.L. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J. Cell Mol Med. 14, 2190–2199 (2010).

2. Parekkadan, B. & Milwid, J.M. Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87–117 (2010).

3. Weiss, D.J., Kolls, J.K., Ortiz, L.A., Panoskaltsis-Mortari, A. & Prockop, D.J. Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 5, 637–667 (2008).

4. Matthay, M.A., Goolaerts, A., Howard, J.P. & Lee, J.W. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit. Care Med. 38, S569–S573 (2010).

5. Rubenfeld, G.D. et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353, 1685–1693 (2005).

Cited by 1196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A promising therapeutic: Exosome-mediated mitochondrial transplantation;International Immunopharmacology;2024-12

2. Artificial mitochondrial transplantation (AMT) reverses aging of mesenchymal stromal cells and improves their immunomodulatory properties in LPS-induced synoviocytes inflammation;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

3. Mitochondrial Transfer as a Strategy for Enhancing Cancer Cell Fitness:Current Insights and Future Directions;Pharmacological Research;2024-10

4. Unraveling the Complexities of Mesenchymal Stromal Cell-based Therapies: One Size Doesn’t Fit All;American Journal of Respiratory and Critical Care Medicine;2024-09-15

5. Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges;Signal Transduction and Targeted Therapy;2024-09-13